Radiologists 'walk' in contrast conflict by Bateman, Chris
August 2003, Vol. 93, No. 8  SAMJ
IZINDABA
The looming loss by radiologists of
R100 million in profit on contrast
medium and the South African Medical
Association’s refusal to back technical
moves to avoid it has led to the
Radiological Association of South Africa
leaving SAMA.
Imminent regulations creating a
single exit price for drug manufacturers,
effectively banning discounts plus
increasing ‘corporatisation’ of radiology
practices, are the major reason behind
an RSSAbid to adjust the charging
structures.
SAMAand the RSSAare in profound
disagreement over how to respond to
the legislation, which allegedly stands
to reduce radiologists’ overall income
by up to 40%.This disagreement
contributed directly to last month’s
unprecedented walk-out by a specialist
group.
The RSSAwants to either increase the
units allocated to procedure codes or
have the contrast medium profit
included in the new professional
dispensing fee. SAMAhowever insists
that this amounts to ‘hiding profits’,
skews the price coding system (which
operates on inter-disciplinary relative
values), making it ‘unscientific’.
SAMAargues that demands such as
the RSSA’s militate against the overall
interests and credibility of the medical
profession.
‘We’re saying you cannot convert
profit on a consumable into a
professional fee,’ said one well-placed
SAMAnegotiator who refused to be
named for fear of ‘aggravating
relations’.
Sources within radiology cited mark-
ups (including discounts) on contrast
medium of up to 234% and higher –
with further drug company incentives
such as free overseas trips.
One radiologist claimed that RSSA
negotiations with drug companies and
the Board of Health Care Funders (BHF)
on the contrast medium selling price
resulted in over R100 million in
‘overcharges’ to patients annually.
Richard Tuft, President of the RSSA,
confirmed that the annual contrast
medium profit was R100 million but
emphasised that this constituted 5% of
the annual payout to radiology (R2
billion).
The SAMJ calculated that if all
registered diagnostic radiologists in
South Africa (564) are practising, this
puts contrast medium profit at R177 304
per radiologist per year.
The legislation is aimed directly at
making drugs affordable to more people
and slashing the massive profits
currently generated between the source
and the end-consumer.
Tuft said that since negotiations with
the BHF began in 2000, his organisation
had fixed the selling price to reduce the
mark up, thus preventing drug
companies from increasing their
discounts.
‘We’ve been the only group who
actively tried to do something about
this over the past three or so years.
Drug companies were pushing the price
up – we held it down,’ he said.
He said that while the profits on
discounts were admittedly ‘enormous’
there was ‘no question of hiding this –
we’ve been trying to negotiate to source
this income elsewhere for three years’.
The SAMJ’s radiologist source, who
asked to remain anonymous, cited one
example of a pre-filled syringe of  
50 ml/300 mg of a well-known brand of
contrast medium being ‘ethically’ listed
at R396.58. For this the radiologists paid
R142.27 (after discounts) and charged
patients R474.40 (all prices excluding
VAT) – a mark-up of 234%.
He claimed this pricing was regularly
exceeded.
‘To my knowledge all radiologists,
including members of the executive, get
such discounts and indeed, greater
discounts,’ he said. Tuft responded: ‘We
don’t believe this is any different to the
discount mark-up structures that other
doctors receive’.
Oncology is another speciality that
stands to lose millions in profits when
the drug-pricing clampdown kicks in.
The legislation amending the
Medicines and Related Substances
Control Act (101 of 1965) was gazetted
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in 1997, but regulations were drawn up
and time-framed this year.
From 2 May next year the
pharmaceutical industry will be banned
from offering discounts to registered
health care professionals and
pharmacists. Doctors will have to apply
for dispensing licences (after completing
a supplementary course in dispensing
and being accredited by the Pharmacy
Council).
One well-respected lawyer in the field
characterised reaction from the medical
profession as ‘furious, irrational, ill-
informed and blaming’. She said many
dispensing doctors erroneously believed
that the R25 per script proposed by
pharmacists as a dispensing fee was
proscriptive. The truth was that the
dispensing fee would depend on how
successful applicants were in their
upcoming representations to the
statutory pricing committee.
Nominations for this body of experts,
drawn from legal, medical and
pharmacological disciplines, were called
for on 10 February this year.
The committee is obliged to hold
hearings and uphold the rights and
legitimate expectations of stakeholders,
but had yet to be constituted at the time
of going to press.
Tuft confirmed the deadlock with
SAMAand said the ensuing pull-out of
his society was ‘really about the way
that we handle the profit on contrast
medium’.
‘Asignificant part of radiologists’
income (40%) comes from that – we had
an agreement with the BHF and funders
to put it back into the item it was in by
increasing the number of units into the
procedure. We want to make it a zero
sum exercise for the whole country,’ he
added.
Tuft said this was ‘not dissimilar’ to
the GPs ‘taking the profit out of
dispensing and putting it into the
professional fee’.
‘We just wanted to increase our
professional fee to keep our income the
same,’ he stressed.
Another issue the RSSAhad put
before SAMA’s Specialist Private
Practice Committee (SPPC) was for an
exchange rate modifier, because
radiologists were ‘very dependent on
importing equipment’.
‘But they were against that too,’
claimed Tuft.
SAMAchairman, Dr Kgosi Letlape,
rejected this and stressed that SAMA
was a voluntary organisation ‘whose
future depends on us acting in the
interests of the patient first and the
interests of the collective body of
medical practitioners second’.
Letlape said that the RSSA’s move
‘raises the issue of people using the
association for their own benefit and
then disappearing and exposing all
other practitioners to fragmentation and
less power and ability to save
ourselves’. SAMAwould ensure that
those radiologists who chose to remain
members would find a home within the
umbrella body, he said. 
Tuft said that the RSSAhad
recommended that its members remain
members of SAMA.
‘We’re not trying to smash the
association, we just want to go our own
way,’ he said.
The RSSAfaces a growing and
concerted bid by hospital groups to take
over radiology facilities, raising the
spectre of radiologists being
predominantly employed by hospital
owners to whom more profits would
then accrue. Radiologists would then
only collect on prodecures and lose
major income from consumables like
contrast medium because of the new
law (unless they now significantly
increase their professional fee).
Letlape said he believed the RSSA’s
walk-out was ‘premature without
having had us (SAMA) for an audience
– I’m really concerned about a divided
profession in these difficult times for
health care in South Africa’.
Tuft retorted that every attempt had
been made to engage SAMAand
charged that RSSAproposals to Letlape,
which included remaining in SAMAas
a specialist group, had remained
unacknowledged and that the board
was selectively apprised of
developments. 
The BHF’s chief benefit and risk
officer, Fiona Robertson, confirmed that
the BHF had adopted a principle that
any tariff schedules would be corrected
in accordance with the new law and
that rates agreed upon should be cost
neutral.
‘Technically Tuft is correct, but the
base has now been extended to a third
‘We just wanted to
increase our professional fee
to keep our income the
same,’ he stressed.
The manufacturers of the
contrast medium believe that
they are equally entitled to
part of the redistribution of
the discount.’
Dr Kgosi Letlape.
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party – namely the manufacturers of the
contrast medium who believe that they
are equally entitled to part of the
redistribution of the discount.’ 
This has made discussions just ‘a little
bit more complicated’.
Tuft revealed that the RSSAhad since
agreed to give back 17% of their profit
to the drug companies.
The BHF has also been in a standoff
with SAMAwho claim copyright and
intellectual property rights over existing
descriptor codes which the BHF wants
to amend.
Robertson said she hoped that by
August an agreed model would have
been developed with all parties to
address the issues and provide a new
recommended billing structure for
radiology into the future.
Pressed on what the new model
would look like she said: ‘We’ll need to
understand what percentage is contrast
and what percentage is the professional
fee, so we can break it down and adjust
it in the years to come to accommodate
for contrast’.
The new act was intended to ‘take the
fat out of the system’.
Jan Talma, chairman of the SPPC, said
his committee had an obligation to
address all unitary values on the same
principles. ‘We cannot defend a
structure which has distortions. If a
group can negotiate a good rand value
for units, good for them, but our duty is
to be transparent and fair to all groups –
we need a defendable benchmark,’ he
said.
He described the situation as ‘still
very fluid’ and denied Tuft’s claim that
his committee had rejected the RSSA’s
suggestion of an exchange control
modifier.
Meanwhile struggling GPs, especially
those in rural and low-income urban
areas where they cannot practise good
medicine without dispensing drugs
themselves, are fighting the impending
legislation.
The National Convention on
Dispensing (NCD) were granted a
reprieve by the Pretoria High Court
after challenging the readiness of the
State to deal with their drug dispensing
licence applications within a
compulsory 12-month period.
They have applied to have the
legislation declared null and void,
arguing that at the very least, current
State inefficiency could deny them the
right to continue dispensing.
Judge Eberhardt Bertelsman declined
the State’s request to refuse the NCD’s
application and postponed the matter to
21 October this year for review.
This means that if significant progress
is not made by the Department of
Health in making it possible for doctors
to become fairly and reasonably
licensed by that date, the NCD can
apply to have the 2 May 2004 deadline
for the new dispensation struck down.
Norman Mabasa, a spokesman for the
NCD, said dispensing doctors wanted
the MDPB or HPCSAto administer a
‘refresher course, rather than have us
write an exam run by pharmacists’. A
grandfather clause is also under
negotiation, the SAMJ learnt.
Mabasa said the legislation had not
taken account of 80% of South Africans
not being covered by medical aids nor
that GPs currently held a monopoly on
dispensing HIV antiretroviral drugs.
‘If they can prove there are no poor
people in rural areas, I’ll accept this law
provided they allow rural doctors to
dispense,’ he countered.
Mabasa claimed doctors ‘just want to
provide a complete service’, and would
in any case be prevented by the new
law from making any drug profits, ‘so
profit is a non-issue with us’.
‘Whether we dispense or not, GPs are
underpaid – we get just 7% of the total
payout and specialists get 23%, yet we
outnumber them by three to one,’ he
added.
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